Related Experiment Video
Updated: Aug 22, 2026

Production of Autologous Platelet-Rich Plasma for Boosting In Vitro Human Fibroblast Expansion
Published on: February 24, 2021
The use of recombinant human erythropoietin stimulating factor in plastic surgery
G A Ferraro1, A Corcione, G F Nicoletti
1Via Campiglione, 18, 80122 Naples, Italy. gaferraro@libero.it
Abstract:
Erythropoietin is the most important factor in the regulation of erythropoiesis. This study aimed to evaluate the efficacy of rhuESF for patients undergoing plastic surgical procedures during which notable blood loss is expected (reduction mammoplasty in cases of macromastia and abdominoplasty obese patients) to improve the full blood count and reduce the need for transfusion. The levels of hemoglobin were significantly greater for patients pretreated with erythropoietin and iron than for the control group.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
iPS Cell Differentiation
